Immutep Announces Data Presentations at Upcoming Industry Conferences
(WorldNews Business)

ASX/Media Release (Code: ASX: IMM; NASDAQ: IMMP) Immutep Announces Data Presentations at Upcoming Industry Conferences SYDNEY, AUSTRALIA - October 10, 2019 - Immutep Limited(ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced that clinical data on the Company`s lead product candidate eftilagimod alpha ("efti" or "IMP321"), a soluble LAG-3Ig fusion protein based on the LAG-3 immune control mechanism, will be presented at two industry conferences in October and November 2019. Conference: World Immunotherapy Congress as part of Festival...